The importance of positron emission tomography/computed tomography (PET-CT) to identify distant metastasis in non-small cell lung cancer (NSCLC) Source: Annual Congress 2010 - Staging of lung cancer Year: 2010
Correlatin between PET scan and cytokine in non-small cell lung cancer (NSCLC) Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012
Preoperative evaluation of locally advanced non-small cell lung cancer after induction therapy by positron emission tomography with F-18-fluorodeoxyglucose (FDG-PET) Source: Eur Respir J 2004; 24: Suppl. 48, 457s Year: 2004
PET scanning poorly predicts response to pre-operative chemotherapy in non-small cell lung cancer Source: ISSN=ISSN 1810-6838, ISBN=, page=54 Year: 2004
Staging and restaging in the era of multimodality treatment Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer Year: 2006
Prognostic value of primary tumour maximum standardized uptake value (SUV max) in non small cell lung cancer (NSCLC) with F18-fluorodeoxyglucose positron emission tomography (FDG-PET): a systematic review and meta-analysis (MA) by the European Lung Cancer Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology Year: 2007
The role of positron emission tomography scan in the preoperative staging of nonsmall cell lung cancer Source: Annual Congress 2008 - Diagnostic and therapeutic problems in thoracic surgery Year: 2008
Incidental detection by computed tomography is an independent prognostic factor for survival in patients operated for nonsmall cell lung carcinoma Source: ERJ Open Res, 3 (2) 00106-2016; 10.1183/23120541.00106-2016 Year: 2017
Preoperative FDG uptake on PET/CT predicts disease recurrence and survival in early stage non-small cell lung cancer (NSCLC) Source: International Congress 2016 – Clinical aspects of lung cancer Year: 2016
The effect of positron emission tomography (PET-CT) on the management of patients with non-small cell lung cancer (NSCLC) prior to oncological treatment Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014
Extra-mediastinal FDG-PET hot-spots in a study of mediastinal staging of non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 458s Year: 2004
FDG-PET SUVmax is an independent prognostic indicator in patients with non-small cell lung cancer Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients Year: 2011
Prognostic value of integrated FDG-PET/CT in non-small cell lung cancer Source: Annual Congress 2008 - New imaging techniques in chest imaging Year: 2008
PET/CT of lung cancer Source: International Congress 2018 – PG4 Imaging of the chest Year: 2018
Comparision of FDG PET/CT and bone scanning for bone metastases in operable non-small cell lung cancer Source: Annual Congress 2009 - Management of thoracic malignancies Year: 2009
Surgery for nonsmall cell lung cancer: can improvements be made? Source: Eur Respir J 2003; 21: 52S-56S Year: 2003
N-staging in CT N0 -N1 non-small cell lung cancer patients: is there any place for mediastinoscopy? Source: Annual Congress 2007 - Staging, diagnostic procedures and complex situations in thoracic surgery Year: 2007
Synchronous primary malignancies identified during staging 18F-FDG PET scan in lung cancer patients Source: Annual Congress 2010 - Staging of lung cancer Year: 2010
PET scan in stage IA lung cancer Source: Eur Respir J 2007; 30: Suppl. 51, 436s Year: 2007
Management of a large tumour Source: Annual Congress 2005 - Oncology Grand Round: an interactive session Year: 2005